Get detailed at https://bisresearch.com/industry-report/europe-hereditary-genetic-testing-market.html. BIS healthcare experts have found hereditary genetic testing to be one of the most rapidly evolving markets. The market for Europe hereditary genetic testing is predicted to grow at a CAGR of 13.34% during the forecast period 2021-2031.

1. 1
All rights reserved at BIS Research Inc.
E
u
r
o
p
e
H
e
r
e
d
i
t
a
r
y
G
e
n
e
t
i
c
T
e
s
t
i
n
g
M
a
r
k
e
t
re
Focus on Products, Sample Type,
Applications, and Nordic and Baltic Region,
Country Data (12 Countries), and
Competitive Landscape
Analysis and Forecast: 2020-2031
October 2021
Europe
Hereditary
Genetic Testing
Market -
A Regional
Analysis
Table of Content

2. 2
All rights reserved at BIS Research Inc.
E
u
r
o
p
e
H
e
r
e
d
i
t
a
r
y
G
e
n
e
t
i
c
T
e
s
t
i
n
g
M
a
r
k
e
t
BIS Research is a leading market intelligence and technology research company. BIS Research publishes in-
depth market intelligence reports focusing on the market estimations, technology analysis, emerging high-
growth applications, deeply segmented granular country-level market data and other important market
parameters useful in the strategic decision making for senior management. BIS Research provides multi-client
reports, company profiles, databases, and custom research services.
Copyright © 2021 BIS Research Inc.
All Rights Reserved. This document contains highly confidential information and is the sole property of BIS
Research. Disclosing, copying, circulating, quoting, or otherwise reproducing any or all contents of this
document is strictly prohibited. Access to this information is provided exclusively for the benefit of the people
or organization concerned. It may not be accessed by or offered whether for sale or otherwise to any third
party.

3. 3
All rights reserved at BIS Research Inc.
E
u
r
o
p
e
H
e
r
e
d
i
t
a
r
y
G
e
n
e
t
i
c
T
e
s
t
i
n
g
M
a
r
k
e
t
Table of Content
Executive Summary..........................................................................20
Research Methodology.....................................................................25
1. Market Overview........................................................................31
1.1 Market Definition..............................................................................................32
1.2 Inclusions and Exclusions..............................................................................32
1.3 Current State of Hereditary Genetic Testing in Europe................................33
1.4 Market Footprint and Future Potential...........................................................33
1.5 Realistic and Optimistic View of Europe Hereditary Genetic Testing
Market ...............................................................................................................35
2. Industry Analysis .......................................................................37
2.1 Regulatory Framework in Europe ..................................................................38
2.1.1 Overview ......................................................................................................39
2.1.2 Legal Requirements ....................................................................................39
2.1.3 Workflow ......................................................................................................40
2.1.4 Reimbursement Scenario ...........................................................................41
3. Market Dynamics .......................................................................42
3.1 Market Dynamics .............................................................................................43
3.1.1 Drivers..........................................................................................................43
3.1.1.1 Increasing Awareness Toward Hereditary Genetic Testing............................... 43
3.1.1.2 Rising Prevalence of Genetic Disorders ............................................................ 44
3.1.1.3 Increasing Research Funding in the Field of Genomics .................................... 44
3.1.2 Restraints.....................................................................................................45
3.1.2.1 High Cost of Genetic Testing............................................................................. 45
3.1.2.2 Stringent Regulatory Standards......................................................................... 45
3.1.3 Opportunities...............................................................................................46
3.1.3.1 Technological Advancements in the Hereditary Genetic Testing Process ........ 46

4. 4
All rights reserved at BIS Research Inc.
E
u
r
o
p
e
H
e
r
e
d
i
t
a
r
y
G
e
n
e
t
i
c
T
e
s
t
i
n
g
M
a
r
k
e
t
3.1.3.2 Growing Demand for Direct-to-Consumer (DTC) Testing Service..................... 47
4. Competitive Landscape.............................................................48
4.1 Overview...........................................................................................................49
4.2 Synergistic Activities ......................................................................................50
4.2.1 Mergers and Acquisitions (M&A) ...............................................................51
4.2.2 New Product Launches...............................................................................52
4.2.3 Product Approvals ......................................................................................52
4.2.4 Business Expansions .................................................................................52
4.3 Market Share Analysis, By Company.............................................................53
4.4 Growth Share Analysis, By Company............................................................55
4.4.1 Inference ......................................................................................................55
4.4.2 Inference ......................................................................................................57
5. Product.....................................................................................58
5.1 Overview...........................................................................................................59
5.1.1 Kits................................................................................................................61
5.1.2 Consumables...............................................................................................62
5.1.3 Services........................................................................................................63
5.1.4 Others...........................................................................................................64
6. Sample Type .............................................................................66
6.1 Overview...........................................................................................................67
6.1.1 Tumor Tissue...............................................................................................68
6.1.2 Bone Marrow................................................................................................69
6.1.3 Blood ............................................................................................................70
6.1.4 Saliva............................................................................................................71
6.1.5 Others...........................................................................................................71
7. Applications..............................................................................73

5. 5
All rights reserved at BIS Research Inc.
E
u
r
o
p
e
H
e
r
e
d
i
t
a
r
y
G
e
n
e
t
i
c
T
e
s
t
i
n
g
M
a
r
k
e
t
7.1 Overview...........................................................................................................74
7.1.1 Oncology Genetic Testing..........................................................................76
7.1.1.1 Overview............................................................................................................ 76
7.1.1.2 Breast Cancer.................................................................................................... 77
7.1.1.3 Lung Cancer ...................................................................................................... 77
7.1.1.4 Prostate Cancer................................................................................................. 78
7.1.1.5 Colorectal Cancer.............................................................................................. 79
7.1.1.6 Melanoma.......................................................................................................... 80
7.1.1.7 Other Oncology Genetic Testing Type .............................................................. 81
7.1.2 Cardiology Genetic Testing Type...............................................................82
7.1.2.1 Overview............................................................................................................ 82
7.1.2.2 Cardiomyopathy................................................................................................. 83
7.1.2.3 Aortopathy ......................................................................................................... 84
7.1.2.4 Arrhythmia ......................................................................................................... 85
7.1.2.5 Other Cardiology Genetic Testing Type ............................................................ 85
7.1.3 Neurology Genetic Testing Type................................................................86
7.1.3.1 Epilepsy ............................................................................................................. 87
7.1.3.2 Neurodegenerative Disorders............................................................................ 88
7.1.3.3 Neuromuscular Disorders.................................................................................. 89
7.1.3.4 Other Neurology Testing Type........................................................................... 89
7.1.4 Newborn Screening.....................................................................................90
7.1.5 Prenatal Screening and Preimplantation Testing.....................................91
7.1.6 Rare Disease Testing ..................................................................................92
7.1.7 Direct-to-Consumer (DTC) Testing ............................................................93
8. Regions.....................................................................................94
8.1 Europe ..............................................................................................................95
8.1.1 Overview ......................................................................................................95
8.2 EU5..................................................................................................................101

6. 6
All rights reserved at BIS Research Inc.
E
u
r
o
p
e
H
e
r
e
d
i
t
a
r
y
G
e
n
e
t
i
c
T
e
s
t
i
n
g
M
a
r
k
e
t
8.2.1 Germany.....................................................................................................101
8.2.2 U.K. .............................................................................................................102
8.2.3 France.........................................................................................................103
8.2.4 Italy .............................................................................................................104
8.2.5 Spain...........................................................................................................105
8.3 Nordic Region ................................................................................................107
8.3.1 Finland........................................................................................................107
8.3.1.1 Finland Hereditary Genetic Testing Market (by Product)................................. 108
8.3.1.2 Finland Hereditary Genetic Testing Market (by Sample Type)........................ 108
8.3.1.3 Finland Hereditary Genetic Testing Market (by Application) ........................... 109
8.3.1.4 Finland Hereditary Genetic Testing Market (by Oncology Genetic Testing
Application)...................................................................................................... 109
8.3.1.5 Finland Hereditary Genetic Testing Market (by Cardiology Genetic Testing
Application)...................................................................................................... 110
8.3.1.6 Finland Hereditary Genetic Testing Market (by Neurology Genetic Testing
Application)...................................................................................................... 110
8.3.2 Sweden.......................................................................................................111
8.3.2.1 Sweden Hereditary Genetic Testing Market (by Product) ............................... 111
8.3.2.2 Sweden Hereditary Genetic Testing Market (by Sample Type)....................... 112
8.3.2.3 Sweden Hereditary Genetic Testing Market (by Application) .......................... 112
8.3.2.4 Sweden Hereditary Genetic Testing Market (by Oncology Genetic Testing
Application)...................................................................................................... 113
8.3.2.5 Sweden Hereditary Genetic Testing Market (by Cardiology Genetic Testing
Application)...................................................................................................... 113
8.3.2.6 Sweden Hereditary Genetic Testing Market (by Neurology Genetic Testing
Application)...................................................................................................... 114
8.3.3 Denmark.....................................................................................................114
8.3.3.1 Denmark Hereditary Genetic Testing Market (by Product).............................. 115
8.3.3.2 Denmark Hereditary Genetic Testing Market (by Sample Type) ..................... 115
8.3.3.3 Denmark Hereditary Genetic Testing Market (by Application)......................... 116

7. 7
All rights reserved at BIS Research Inc.
E
u
r
o
p
e
H
e
r
e
d
i
t
a
r
y
G
e
n
e
t
i
c
T
e
s
t
i
n
g
M
a
r
k
e
t
8.3.3.4 Denmark Hereditary Genetic Testing Market (by Oncology Genetic Testing
Application)...................................................................................................... 116
8.3.3.5 Denmark Hereditary Genetic Testing Market (by Cardiology Genetic
Testing Application) ......................................................................................... 117
8.3.3.6 Denmark Hereditary Genetic Testing Market (by Neurology Genetic
Testing Application) ......................................................................................... 117
8.3.4 Norway .......................................................................................................118
8.3.4.1 Norway Hereditary Genetic Testing Market (by Product) ................................ 118
8.3.4.2 Norway Hereditary Genetic Testing Market (by Sample Type) ....................... 119
8.3.4.3 Norway Hereditary Genetic Testing Market (by Application) ........................... 119
8.3.4.4 Norway Hereditary Genetic Testing Market (by Oncology Genetic Testing
Application)...................................................................................................... 120
8.3.4.5 Norway Hereditary Genetic Testing Market (by Cardiology Genetic Testing
Application)...................................................................................................... 120
8.3.4.6 Norway Hereditary Genetic Testing Market (by Neurology Genetic Testing
Application)...................................................................................................... 121
8.4 Baltic Region..................................................................................................123
8.4.1 Estonia .......................................................................................................123
8.4.1.1 Estonia Hereditary Genetic Testing Market (by Product) ................................ 124
8.4.1.2 Estonia Hereditary Genetic Testing Market (by Sample Type)........................ 124
8.4.1.3 Estonia Hereditary Genetic Testing Market (by Application) ........................... 125
8.4.1.4 Estonia Hereditary Genetic Testing Market (by Oncology Genetic Testing
Application)...................................................................................................... 125
8.4.1.5 Estonia Hereditary Genetic Testing Market (by Cardiology Genetic Testing
Application)...................................................................................................... 126
8.4.1.6 Estonia Hereditary Genetic Testing Market (by Neurology Genetic Testing
Application)...................................................................................................... 126
8.4.2 Lithuania ....................................................................................................127
8.4.2.1 Lithuania Hereditary Genetic Testing Market (by Product).............................. 127
8.4.2.2 Lithuania Hereditary Genetic Testing Market (by Sample Type) ..................... 128
8.4.2.3 Lithuania Hereditary Genetic Testing Market (by Application)......................... 128

8. 8
All rights reserved at BIS Research Inc.
E
u
r
o
p
e
H
e
r
e
d
i
t
a
r
y
G
e
n
e
t
i
c
T
e
s
t
i
n
g
M
a
r
k
e
t
8.4.2.4 Lithuania Hereditary Genetic Testing Market (by Oncology Genetic Testing
Application)...................................................................................................... 129
8.4.2.5 Lithuania Hereditary Genetic Testing Market (by Cardiology Genetic
Testing Application) ......................................................................................... 129
8.4.2.6 Lithuania Hereditary Genetic Testing Market (by Neurology Genetic
Testing Application) ......................................................................................... 130
8.4.3 Latvia..........................................................................................................130
8.4.3.1 Latvia Hereditary Genetic Testing Market (by Product)................................... 131
8.4.3.2 Latvia Hereditary Genetic Testing Market (by Sample Type) .......................... 131
8.4.3.3 Latvia Hereditary Genetic Testing Market (by Application).............................. 132
8.4.3.4 Latvia Hereditary Genetic Testing Market (by Oncology Genetic Testing
Application)...................................................................................................... 132
8.4.3.5 Latvia Hereditary Genetic Testing Market (by Cardiology Genetic Testing
Application)...................................................................................................... 133
8.4.3.6 Latvia Hereditary Genetic Testing Market (by Neurology Genetic Testing
Application)...................................................................................................... 133
8.4.4 Rest-of-Europe...........................................................................................135
9. Company Profiles....................................................................136
9.1 Overview.........................................................................................................137
9.2 Agilent Technologies, Inc. ............................................................................138
9.2.1 Company Overview ...................................................................................138
9.2.2 Role of Agilent Technologies, Inc. in the Europe Hereditary Genetic
Testing Market ...........................................................................................138
9.2.3 Financials...................................................................................................139
9.2.4 Key Insights About Financial Health of the Company ...........................141
9.2.5 SWOT Analysis..........................................................................................142
9.3 Woble Helsinki Oy .........................................................................................143
9.3.1 Company Overview ...................................................................................143

9. 9
All rights reserved at BIS Research Inc.
E
u
r
o
p
e
H
e
r
e
d
i
t
a
r
y
G
e
n
e
t
i
c
T
e
s
t
i
n
g
M
a
r
k
e
t
9.3.2 Role of Woble Helsinki Oy in the Europe Hereditary Genetic Testing
Market.........................................................................................................143
9.3.3 SWOT Analysis..........................................................................................145
9.4 Negen Oy........................................................................................................146
9.4.1 Company Overview ...................................................................................146
9.4.2 Role of Negen Oy in the Europe Hereditary Genetic Testing Market....146
9.4.3 SWOT Analysis..........................................................................................147
9.5 Devyser...........................................................................................................148
9.5.1 Company Overview ...................................................................................148
9.5.2 Role of Devyser in the Europe Hereditary Genetic Testing Market.......148
9.5.3 SWOT Analysis..........................................................................................150
9.6 CeGat GmbH ..................................................................................................151
9.6.1 Company Overview ...................................................................................151
9.6.2 Role of CeGaT GmbH in the Europe Hereditary Genetic Testing
Market.........................................................................................................151
9.6.3 SWOT Analysis..........................................................................................153
9.7 Beijing Genomics Institute (BGI)..................................................................154
9.7.1 Company Overview ...................................................................................154
9.7.2 Role of Beijing Genomics Institute (BGI) in the Europe Hereditary
Genetic Testing Market.............................................................................154
9.7.3 SWOT Analysis..........................................................................................156
9.8 BerGenBio ASA .............................................................................................157
9.8.1 Company Overview ...................................................................................157
9.8.2 Role of BerGenBio ASA in the Europe Hereditary Genetic Testing
Market.........................................................................................................157
9.8.3 Financials...................................................................................................158
9.8.4 SWOT Analysis..........................................................................................159
9.9 Eurofins Scientific SE ...................................................................................160

10. 10
All rights reserved at BIS Research Inc.
E
u
r
o
p
e
H
e
r
e
d
i
t
a
r
y
G
e
n
e
t
i
c
T
e
s
t
i
n
g
M
a
r
k
e
t
9.9.1 Company Overview ...................................................................................160
9.9.2 Role of Eurofins Scientific SE in the Europe Hereditary Genetic
Testing Market ...........................................................................................160
9.9.3 Financials...................................................................................................161
9.9.4 SWOT Analysis..........................................................................................162
9.10 F. Hoffmann-La Roche Ltd............................................................................163
9.10.1 Company Overview ...................................................................................163
9.10.2 Role of F. Hoffmann-La Roche Ltd in the Europe Hereditary Genetic
Testing Market ...........................................................................................163
9.10.3 Financials...................................................................................................164
9.10.4 Key Insights About Financial Health of the Company ...........................166
9.10.5 SWOT Analysis..........................................................................................167
9.11 Illumina, Inc....................................................................................................168
9.11.1 Company Overview ...................................................................................168
9.11.2 Role of Illumina, Inc. in the Europe Hereditary Genetic Testing
Market.........................................................................................................168
9.11.3 Financials...................................................................................................169
9.11.4 Key Insights About Financial Health of the Company ...........................170
9.11.5 SWOT Analysis..........................................................................................171
9.12 Myriad Genetics, Inc......................................................................................172
9.12.1 Company Overview ...................................................................................172
9.12.2 Role of Myriad Genetics, Inc. in the Europe Hereditary Genetic
Testing Market ...........................................................................................172
9.12.3 Financials...................................................................................................173
9.12.4 Key Insights About Financial Health of the Company ...........................174
9.12.5 SWOT Analysis..........................................................................................175
9.13 Alnylam Pharmaceuticals, Inc. .....................................................................176
9.13.1 Company Overview ...................................................................................176

11. 11
All rights reserved at BIS Research Inc.
E
u
r
o
p
e
H
e
r
e
d
i
t
a
r
y
G
e
n
e
t
i
c
T
e
s
t
i
n
g
M
a
r
k
e
t
9.13.2 Role of Alnylam Pharmaceuticals, Inc., in Europe Hereditary
Genetic Testing Market.............................................................................176
9.13.3 Financials...................................................................................................177
9.13.4 Key Insights About Financial Health of the Company ...........................178
9.13.5 SWOT Analysis..........................................................................................179
9.14 Quest Diagnostics Incorporated ..................................................................180
9.14.1 Company Overview ...................................................................................180
9.14.2 Role of Quest Diagnostics Incorporated in the Europe Hereditary
Genetic Testing Market.............................................................................180
9.14.3 Financials...................................................................................................181
9.14.4 SWOT Analysis..........................................................................................183
9.15 Thermo Fisher Scientific Inc.........................................................................184
9.15.1 Company Overview ...................................................................................184
9.15.2 Role of Thermo Fisher Scientific Inc. in the Europe Hereditary
Genetic Testing Market.............................................................................184
9.15.3 Financials...................................................................................................185
9.15.4 Key Insights About Financial Health of the Company ...........................187
9.15.5 SWOT Analysis..........................................................................................188

12. 12
All rights reserved at BIS Research Inc.
E
u
r
o
p
e
H
e
r
e
d
i
t
a
r
y
G
e
n
e
t
i
c
T
e
s
t
i
n
g
M
a
r
k
e
t
List of Figures
Figure 1: Europe Hereditary Genetic Testing Market, Realistic and Optimistic Scenario, $Million,
2020-2031
Figure 2: Europe Hereditary Genetic Testing Market Dynamics
Figure 3: Share of Key Market Strategies and Developments, January 2018-March 2021
Figure 4: Growth Share Matrix for Europe Hereditary Genetic Testing Market (by Company),
2019 and 2020
Figure 5: Growth Share Matrix for Nordic and Baltic Hereditary Genetic Testing Market (by
Company), 2019 and 2020
Figure 6: Europe Hereditary Genetic Testing Market Research Methodology
Figure 7: Primary Research Methodology
Figure 8: Incremental Opportunity: Europe Hereditary Genetic Testing Market, $Million, 2020-2031
Figure 9: Realistic and Optimistic View of Europe Hereditary Genetic Testing Market, $Million,
2020-2031
Figure 10: Europe Hereditary Genetic Testing Market Dynamics
Figure 11: Share of Key Market Strategies and Developments, January 2018-March 2021
Figure 12: Share of Synergistic Activities (by Company), January 2018-March 2021
Figure 13: Mergers and Acquisitions (M&A) Activities, January 2018-March 2021
Figure 14: New Product Launches, January 2018-March 2021
Figure 15: Market Share Analysis for Europe Hereditary Genetic Testing Market, $Million,
2019 and 2020
Figure 16: Market Share Analysis for Nordic and Baltic Hereditary Genetic Testing Market,
2019 and 2020
Figure 17: Growth Share Matrix for Europe Hereditary Genetic Testing Market (by Company),
2019 and 2020
Figure 18: Growth Share Matrix for Nordic and Baltic Hereditary Genetic Testing Market (by
Company), 2019 and 2020
Figure 19: Europe Hereditary Genetic Testing Market (by Product)
Figure 20: Share of Europe Hereditary Genetic Testing Market (by Product), $Million, 2020 and 2031
Figure 21: Share of Nordic and Baltic Hereditary Genetic Testing Market (by Product), $Million,
2020 and 2031
Figure 22: Europe Hereditary Genetic Testing Market (Kits), $Million, 2020-2031
Figure 23: Europe Hereditary Genetic Testing Market (Consumables), $Million, 2020-2031
Figure 24: Europe Hereditary Genetic Testing Market (Services), $Million, 2020-2031
Figure 25: Europe Hereditary Genetic Testing Market (Others), $Million, 2020-2031
Figure 26: Europe Hereditary Genetic Testing Market (by Sample Type)
Figure 27: Share of Europe Hereditary Genetic Testing Market (by Sample Type), $Million,
2020 and 2031

13. 13
All rights reserved at BIS Research Inc.
E
u
r
o
p
e
H
e
r
e
d
i
t
a
r
y
G
e
n
e
t
i
c
T
e
s
t
i
n
g
M
a
r
k
e
t
Figure 28: Share of Nordic and Baltic Hereditary Genetic Testing Market (by Sample Type), $Million,
2020 and 2031
Figure 29: Europe Hereditary Genetic Testing Market (Tumor Tissue), $Million, 2020-2031
Figure 30: Europe Hereditary Genetic Testing Market (Bone Marrow), $Million, 2020-2031
Figure 31: Europe Hereditary Genetic Testing Market (Blood Sample), $Million, 2020-2031
Figure 32: Europe Hereditary Genetic Testing Market (Saliva), $Million, 2020-2031
Figure 33: Europe Hereditary Genetic Testing Market (Others), $Million, 2020-2031
Figure 34: Europe Hereditary Genetic Testing Market (by Application)
Figure 35: Europe Hereditary Genetic Testing Market (by Application), $Million, 2020 and 2031
Figure 36: Nordic and Baltic Hereditary Genetic Testing Market (by Application), $Million,
2020 and 2031
Figure 37: Europe Hereditary Genetic Testing Market (Oncology Genetic Testing), $Million,
2020-2031
Figure 38: Europe Hereditary Genetic Testing Market (Breast Cancer), $Million, 2020-2031
Figure 39: Europe Hereditary Genetic Testing Market (Lung Cancer), $Million, 2020-2031
Figure 40: Europe Hereditary Genetic Testing Market (Prostate Cancer), $Million, 2020-2031
Figure 41: Europe Hereditary Genetic Testing Market (Colorectal Cancer), $Million, 2020-2031
Figure 42: Europe Hereditary Genetic Testing Market (Melanoma), $Million, 2020-2031
Figure 43: Europe Hereditary Genetic Testing Market (Other Oncology Genetic Testing), $Million,
2020-2031
Figure 44: Europe Hereditary Genetic Testing Market (Cardiology Genetic Testing Type), $Million,
2020-2031
Figure 45: Europe Hereditary Genetic Testing Market (Cardiomyopathy), $Million, 2020-2031
Figure 46: Europe Hereditary Genetic Testing Market (Aortopathy), $Million, 2020-2031
Figure 47: Europe Hereditary Genetic Testing Market (Arrhythmia), $Million, 2020-2031
Figure 48: Europe Hereditary Genetic Testing Market (Other Cardiology Genetic Testing Type),
$Million, 2020-2031
Figure 49: Europe Hereditary Genetic Testing Market (Neurology Genetic Testing Type), $Million,
2020-2031
Figure 50: Europe Hereditary Genetic Testing Market (Epilepsy), $Million, 2020-2031
Figure 51: Europe Hereditary Genetic Testing Market (Neurodegenerative Disorders), $Million,
2020-2031
Figure 52: Europe Hereditary Genetic Testing Market (Neuromuscular Disorders), $Million,
2020-2031
Figure 53: Europe Hereditary Genetic Testing Market (Other Neurology Testing Type), $Million,
2020-2031
Figure 54: Europe Hereditary Genetic Testing Market (Newborn Screening), $Million, 2020-2031
Figure 55: Europe Hereditary Genetic Testing Market (Prenatal Screening and Preimplantation
Testing), $Million, 2020-2031
Figure 56: Europe Hereditary Genetic Testing Market (Rare Disease Testing), $Million, 2020-2031

14. 14
All rights reserved at BIS Research Inc.
E
u
r
o
p
e
H
e
r
e
d
i
t
a
r
y
G
e
n
e
t
i
c
T
e
s
t
i
n
g
M
a
r
k
e
t
Figure 57: Europe Hereditary Genetic Testing Market (Direct-to-Consumer (DTC) Testing), $Million,
2020-2031
Figure 58: Europe Hereditary Genetic Testing Market, $Million, 2020-2031
Figure 59: Nordic Hereditary Genetic Testing Market, $Million, 2020-2031
Figure 60: Baltic Hereditary Genetic Testing Market, $Million, 2020-2031
Figure 61: Share of Europe Hereditary Genetic Testing Market (by Country), $Million, 2020-2031
Figure 62: Europe: Market Dynamics
Figure 63: Germany Hereditary Genetic Testing Market, $Million, 2020-2031
Figure 64: U.K. Hereditary Genetic Testing Market, $Million, 2020-2031
Figure 65: France Hereditary Genetic Testing Market, $Million, 2020-2031
Figure 66: Italy Hereditary Genetic Testing Market, $Million, 2020-2031
Figure 67: Spain Hereditary Genetic Testing Market, $Million, 2020-2031
Figure 68: Finland Hereditary Genetic Testing Market, $Million, 2020-2031
Figure 69: Finland Hereditary Genetic Testing Market (by Product), $Million, 2020-2031
Figure 70: Finland Hereditary Genetic Testing Market (by Sample Type), $Million, 2020-2031
Figure 71: Finland Hereditary Genetic Testing Market (by Application), $Million, 2020-2031
Figure 72: Finland Hereditary Genetic Testing Market (by Oncology Genetic Testing Application),
$Million, 2020-2031
Figure 73: Finland Hereditary Genetic Testing Market (by Cardiology Genetic Testing Application),
$Million, 2020-2031
Figure 74: Finland Hereditary Genetic Testing Market (by Neurology Genetic Testing Application),
$Million, 2020-2031
Figure 75: Sweden Hereditary Genetic Testing Market, $Million, 2020-2031
Figure 76: Sweden Hereditary Genetic Testing Market (by Product), $Million, 2020-2031
Figure 77: Sweden Hereditary Genetic Testing Market (by Sample Type), $Million, 2020-2031
Figure 78: Sweden Hereditary Genetic Testing Market (by Application), $Million, 2020-2031
Figure 79: Sweden Hereditary Genetic Testing Market (by Oncology Genetic Testing Application),
$Million, 2020-2031
Figure 80: Sweden Hereditary Genetic Testing Market (by Cardiology Genetic Testing Application),
$Million, 2020-2031
Figure 81: Sweden Hereditary Genetic Testing Market (by Neurology Genetic Testing Application),
$Million, 2020-2031
Figure 82: Denmark Hereditary Genetic Testing Market, $Million, 2020-2031
Figure 83: Denmark Hereditary Genetic Testing Market (by Product), $Million, 2020-2031
Figure 84: Denmark Hereditary Genetic Testing Market (by Sample Type), $Million, 2020-2031
Figure 85: Denmark Hereditary Genetic Testing Market (by Application), $Million, 2020-2031
Figure 86: Denmark Hereditary Genetic Testing Market (by Oncology Genetic Testing Application),
$Million, 2020-2031
Figure 87: Denmark Hereditary Genetic Testing Market (by Cardiology Genetic Testing Application),
$Million, 2020-2031

15. 15
All rights reserved at BIS Research Inc.
E
u
r
o
p
e
H
e
r
e
d
i
t
a
r
y
G
e
n
e
t
i
c
T
e
s
t
i
n
g
M
a
r
k
e
t
Figure 88: Denmark Hereditary Genetic Testing Market (by Neurology Genetic Testing Application),
$Million, 2020-2031
Figure 89: Norway Hereditary Genetic Testing Market, $Million, 2020-2031
Figure 90: Norway Hereditary Genetic Testing Market (by Product), $Million, 2020-2031
Figure 91: Norway Hereditary Genetic Testing Market (by Sample Type), $Million, 2020-2031
Figure 92: Norway Hereditary Genetic Testing Market (by Application), $Million, 2020-2031
Figure 93: Norway Hereditary Genetic Testing Market (by Oncology Genetic Testing Application),
$Million, 2020-2031
Figure 94: Norway Hereditary Genetic Testing Market (by Cardiology Genetic Testing Application),
$Million, 2020-2031
Figure 95: Norway Hereditary Genetic Testing Market (by Neurology Genetic Testing Application),
$Million, 2020-2031
Figure 96: Estonia Hereditary Genetic Testing Market, $Million, 2020-2031
Figure 97: Estonia Hereditary Genetic Testing Market (by Product), $Million, 2020-2031
Figure 98: Estonia Hereditary Genetic Testing Market (by Sample Type), $Million, 2020-2031
Figure 99: Estonia Hereditary Genetic Testing Market (by Application), $Million, 2020-2031
Figure 100: Estonia Hereditary Genetic Testing Market (by Oncology Genetic Testing Application),
$Million, 2020-2031
Figure 101: Estonia Hereditary Genetic Testing Market (by Cardiology Genetic Testing Application),
$Million, 2020-2031
Figure 102: Estonia Hereditary Genetic Testing Market (by Neurology Genetic Testing Application),
$Million, 2020-2031
Figure 103: Lithuania Hereditary Genetic Testing Market, $Million, 2020-2031
Figure 104: Lithuania Hereditary Genetic Testing Market (by Product), $Million, 2020-2031
Figure 105: Lithuania Hereditary Genetic Testing Market (by Sample Type), $Million, 2020-2031
Figure 106: Lithuania Hereditary Genetic Testing Market (by Application), $Million, 2020-2031
Figure 107: Lithuania Hereditary Genetic Testing Market (by Oncology Genetic Testing Application),
$Million, 2020-2031
Figure 108: Lithuania Hereditary Genetic Testing Market (by Cardiology Genetic Testing
Application), $Million, 2020-2031
Figure 109: Lithuania Hereditary Genetic Testing Market (by Neurology Genetic Testing
Application), $Million, 2020-2031
Figure 110: Latvia Hereditary Genetic Testing Market, $Million, 2020-2031
Figure 111: Latvia Hereditary Genetic Testing Market (by Product), $Million, 2020-2031
Figure 112: Latvia Hereditary Genetic Testing Market (by Sample Type), $Million, 2020-2031
Figure 113: Latvia Hereditary Genetic Testing Market (by Application), $Million, 2020-2031
Figure 114: Latvia Hereditary Genetic Testing Market (by Oncology Genetic Testing Application),
$Million, 2020-2031
Figure 115: Latvia Hereditary Genetic Testing Market (by Cardiology Genetic Testing Application),
$Million, 2020-2031

16. 16
All rights reserved at BIS Research Inc.
E
u
r
o
p
e
H
e
r
e
d
i
t
a
r
y
G
e
n
e
t
i
c
T
e
s
t
i
n
g
M
a
r
k
e
t
Figure 116: Latvia Hereditary Genetic Testing Market (by Neurology Genetic Testing Application),
$Million, 2020-2031
Figure 117: Rest-of-Europe Hereditary Genetic Testing Market, $Million, 2020-2031
Figure 118: Total Number of Companies Profiled
Figure 119: Agilent Technologies, Inc.: Product Portfolio
Figure 120: Agilent Technologies, Inc.: Overall Financials, 2018-2020
Figure 121: Agilent Technologies, Inc.: Revenue (by Segment), 2018-2020
Figure 122: Agilent Technologies, Inc.: Revenue (by Region), 2018-2020
Figure 123: Agilent Technologies, Inc.: R&D Expenditure, 2018-2020
Figure 124: Agilent Technologies, Inc.: SWOT Analysis
Figure 125: Woble Helsinki Oy: Product Portfolio
Figure 126: Woble Helsinki Oy: SWOT Analysis
Figure 127: Negen Oy: Product Portfolio
Figure 128: Negen Oy: SWOT Analysis
Figure 129: Devyser: Product Portfolio
Figure 130: Devyser: SWOT Analysis
Figure 131: CeGaT GmbH: Product Portfolio
Figure 132: CeGaT GmbH: SWOT Analysis
Figure 133: BGI: Product Portfolio
Figure 134: BGI: SWOT Analysis
Figure 135: BerGenBio ASA: Overall Financials, 2018-2020
Figure 136: BerGenBio ASA: Overall Product Portfolio
Figure 137: BerGenBio ASA: SWOT Analysis
Figure 138: Eurofins Scientific SE: Overall Financials, 2018-2020
Figure 139: Eurofins Scientific SE: Revenue (by Region), 2018-2020
Figure 140: Eurofins Scientific SE.: SWOT Analysis
Figure 141: F. Hoffmann-La Roche Ltd: Product Portfolio
Figure 142: F. Hoffmann-La Roche Ltd: Overall Financials, 2018-2020
Figure 143: F. Hoffmann-La Roche Ltd: Revenue (by Segment), 2018-2020
Figure 144: F. Hoffmann-La Roche Ltd: Revenue (by Region), 2018-2020
Figure 145: F. Hoffmann-La Roche Ltd: R&D Expenditure, 2018-2020
Figure 146: F. Hoffmann-La Roche Ltd: SWOT Analysis
Figure 147: Illumina, Inc.: Product Portfolio
Figure 148: Illumina, Inc.: Overall Financials, 2018-2020
Figure 149: Illumina, Inc.: Revenue (by Segment), 2018-2020
Figure 150: Illumina, Inc.: R&D Expenditure, 2018-2020
Figure 151: Illumina, Inc.: SWOT Analysis
Figure 152: Myriad Genetics, Inc.: Product Portfolio
Figure 153: Myriad Genetics, Inc.: Overall Financials, 2018-2020

17. 17
All rights reserved at BIS Research Inc.
E
u
r
o
p
e
H
e
r
e
d
i
t
a
r
y
G
e
n
e
t
i
c
T
e
s
t
i
n
g
M
a
r
k
e
t
Figure 154: Myriad Genetics, Inc.: Revenue (by Segment), 2018-2020
Figure 155: Myriad Genetics, Inc.: R&D Expenditure,2018-2020
Figure 156: Myriad Genetics, Inc.: SWOT Analysis
Figure 157: Alnylam Pharmaceuticals, Inc.: Overall Financials, 2018-2020
Figure 158: Alnylam Pharmaceuticals, Inc.: Revenue (by Segment), 2018-2020
Figure 159: Alnylam Pharmaceuticals, Inc.: Revenue (by Region), 2018-2020
Figure 160: Alnylam Pharmaceuticals, Inc.: R&D Expenditure, 2018-2020
Figure 161: Alnylam Pharmaceuticals, Inc.: SWOT Analysis
Figure 162: Product Portfolio: Quest Diagnostics Incorporated
Figure 163: Quest Diagnostics Incorporated: Overall Financials, 2018-2020
Figure 164: Quest Diagnostics Incorporated: Revenue (by Segment), 2018-2020
Figure 165: Quest Diagnostics Incorporated: SWOT Analysis
Figure 166: Thermo Fisher Scientific Inc.: Product Portfolio
Figure 167: Thermo Fisher Scientific Inc.: Overall Financials, 2018-2020
Figure 168: Thermo Fisher Scientific Inc.: Revenue (by Segment), 2018-2020
Figure 169: Thermo Fisher Scientific Inc.: Revenue (by Region), 2018-2020
Figure 170: Thermo Fisher Scientific Inc.: R&D Expenditure, 2018-2020
Figure 171: Thermo Fisher Scientific Inc.: SWOT Analysis

18. 18
All rights reserved at BIS Research Inc.
E
u
r
o
p
e
H
e
r
e
d
i
t
a
r
y
G
e
n
e
t
i
c
T
e
s
t
i
n
g
M
a
r
k
e
t
List of Tables
Table 1: Legal and Regulatory Framework

19. 19
All rights reserved at BIS Research Inc.
E
u
r
o
p
e
H
e
r
e
d
i
t
a
r
y
G
e
n
e
t
i
c
T
e
s
t
i
n
g
M
a
r
k
e
t
Disclaimer
BIS Research Inc. provides valuable market intelligence to an exclusive group of customers in response to
orders. The report is licensed for the customer's internal use only and is subject to restrictions set henceforth.
This document and its contents are confidential and may not be further distributed, published, or reproduced,
in whole or in part, by any medium or in any form for any purpose, without the express written consent of BIS
Research Inc. Customer will not disclose the contents of the report, whether directly in any media or indirectly
through incorporation in a database, marketing list, report or otherwise, or use or permit the use of Information
to generate any statistical or other information that is or will be provided to third parties; or voluntarily produce
Information in legal proceedings.
Market reports are based on expectations, estimates, and projections as of the date such information is
available. Any recommendation contained in this report may not be suitable for all investors or businesses.
The market conclusions drawn are necessarily based upon a number of estimates and assumptions that, while
considered reasonable by BIS Research Inc. as of the date of such statements, are inherently subject to
market fluctuations and business, economic and competitive uncertainties, and contingencies.
For more details regarding permission, please contact us:
Email: sales@bisresearch.com
Tel: +1 510 404 8135

20. 20
All rights reserved at BIS Research Inc.
E
u
r
o
p
e
H
e
r
e
d
i
t
a
r
y
G
e
n
e
t
i
c
T
e
s
t
i
n
g
M
a
r
k
e
t
BIS RESEARCH INC.
39111 Paseo Padre PKWY, Suite 313 Fremont, CA 94538 -1686
E-mail: hello@bisresearch.com | Call Us: +1-510-404-8135
Global Delivery Center
Tower B First Floor, Tapasya Corporate Heights, Greater Noida Expressway,
Sector 126, Noida, U.P., 201303, India
Tel: +91 120 4261540 / 4261544
www.bisresearch.com